Under state-level policy changes, recreational use of cannabis has increased across the US, bringing increases in marketing, product type, potency, and availability. These factors, combined with lowered perception of risk for cannabis use, warrants an understanding into approaches for cannabis use risk identification, and new motivational intervention techniques to effectively engage with and treat patients. This TA session will include an overview of cannabis research and introduce using the screening brief intervention and referral (SBIRT) with new clinical tools that screen for cannabis use to advance behavioral health integration and clinical practice.
Presenters: Win Turner, PhD; Joe Hyde, MA, LMHC, CAS
Dr. Win Turner, PhD, is a clinical psychologist, evaluator, and instructor in SBIRT, Motivational Interviewing, Cognitive Behavior Therapy, Effective Interventions for Youth & Families and Healthcare Integration. Currently, Dr. Turner's primary work is helping communities increase the capacity to deliver effective integrated healthcare for substance use, co-occurring disorders and other social determinants impacting wellness. Dr. Turner is helping to advance integrated care in hospital departments, community medical centers and other entities through program development, evaluation, and training.
Joseph Hyde, MA, LMHC, CAS, has more than 35 years of experience in substance use prevention, intervention, and treatment. In collaboration with SAMHSA and American Society of Addiction Medicine, he planned and conducted SAMHSA’s Physician Training for Use of Buprenorphine in multiple states. He has developed curriculum and training videos for SAMHSA SBIRT medical residency and health professional training grantees. He served as a trainer for the SAMHSA/NIDA Blended Initiative Certified Buprenorphine Training.
Earn 1.0 continuing education credit for attending this session.